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Non-pharmacological interventions for sleep and quality of life: 
a randomized pilot study*
Objective: to estimate the effects of non-pharmacological interventions to improve the quality 
of sleep and quality of life of patients with heart failure. Method: pilot study of a randomized 
controlled trial with 32 individuals assigned to four groups. Sleep was assessed using the 
Pittsburgh Sleep Quality Inventory, while health-related quality of life was assessed using the 
Minnesota Living with Heart Failure Questionnaire, at the baseline and at the 12th and 24th weeks. 
The means of the outcomes according to intervention groups were compared using analysis of 
covariance; effect sizes were calculated per group. Results: all groups experienced improved 
quality of sleep and health-related quality of life at the end of the intervention (week 12) and at 
follow-up (week 24), though differences were not statistically significant (p between 0.22 and 
0.40). The effects of the interventions at the 12th week ranged between -2.1 and -3.8 for the 
quality of sleep and between -0.8 and -1.7 for quality of life, with similar values at the 24th week. 
Conclusion: the effects found in this study provide information for sample size calculations and 
statistical power for confirmatory studies. Brazilian Clinical Trials Registry - RBR 7jd2mm
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Introduction
Nurses have an essential role in the care provided 
to patients with heart failure (HF), teaching self-
care and encouraging adherence to treatment(1-3). 
Quality of life of these patients can be improved 
when clinical conditions are well-managed and under 
control. Nursing interventions are essential to relieving 
symptoms that limit wellbeing in persons with HF, 
especially among outpatients. 
Sleep changes negatively influence wellbeing and 
quality of life among populations with cardiovascular 
diseases(1–2), impairing self-care practices(3), and 
increasing the risk of unplanned hospitalizations(3-4). 
Sleep disorders are associated with the level of 
severity of the disease, as its progression can cause 
difficulties to falling asleep and maintaining sleep, and 
negatively affecting the lives of patients with HF(5-7).
Studies have reported an association between 
sleep and quality of life in various populations of 
patients(8), including those with HF(9), and it is believed 
that interventions aimed to decrease sleep disorders 
improve the quality of life of these patients(10).
Various studies have used non-pharmacological 
interventions in different populations with the 
objective of improving quality of sleep. Interventions 
included cognitive-behavioral therapy (CBT)(11-12), 
phototherapy(13-14), the teaching of sleep hygiene 
habits(11,14-16), and relaxation techniques(17). Nursing 
interventions combining two or more therapies have 
also been described in the literature(18-20), but little is 
known about the effects, mechanisms of action, and 
applicability of these interventions to improving the 
quality of life of individuals with HF.
Phototherapy refers to regular exposure to light 
and can be used to improve sleep. There is evidence 
that exposure to morning light benefits individuals 
with delayed sleep problems and/or seasonal 
sleep disorders(21-22). One study conducted with 
institutionalized elderly individuals shows that light 
exposure during the morning improves total time of 
sleep during night(23). Phototherapy is well-tolerated 
and presents very few adverse effects(22).  
Sleep hygiene or sleep education is also a non-
pharmacological treatment commonly used to improve 
sleep quality(24-27). This practice consists of changing 
behaviors that hinder good quality sleep. Behaviors 
and habits that may harm sleep include: frequent day 
naps; intense physical activity at night; insufficient 
sun exposure; excessive consumption of caffeine 
and/or alcohol; smoking or eating in excess at night; 
excessive lighting and/or noise in the bedroom; and 
anxiety, among others(28-29). One study compared two 
groups, where 17 patients were randomly assigned 
to the interventions and the group that performed 
sleep hygiene together with exercises presented 
improved sleep, while the control group presented no 
improvement(29).
Resources destined to the health field are finite in 
any country; thus, low cost efficacious interventions 
are ideal. Therefore, there is a need to assess the 
feasibility and potential effect of non-pharmacological 
nursing interventions to improve the sleep patterns of 
individuals with HF.
In order to support the planning of a more 
controlled confirmatory study using a larger sample, 
a pilot study is usually conducted before a complex 
study with various interventions is implemented 
(30-31). This pilot study estimated the effects of non-
pharmacological interventions on the quality of sleep 
and quality of life of patients with heart failure. 
Method
This study followed recommendations provided 
by the Consolidated Standards of Reporting Trials 
(CONSORT)(32). People with heart failure were recruited 
over a period of five months (July-November, 2013) 
from the HF outpatient clinic of a large cardiology 
service. The recruiting period defined the sample 
size for this pilot study of a randomized clinical trial. 
Inclusion criteria were: patients older than 18 years 
old with a medical diagnosis of HF; functional class 
I, II or III(33); presenting stable clinical conditions 
that allowed them to participate in the study; and 
having telephone access. Exclusion criteria were: 
having cognitive impairment according to Folstein 
test(34) or being a good sleeper (score≤5) based on 
the Pittsburgh Sleep Quality Index (PSQI)(35), which is 
described in detail below.
Eligible individuals who consented to participate 
and signed free and informed consent forms were 
randomly assigned to one of the four intervention 
groups (eight individuals per group, totaling 32 
participants): control; phototherapy; sleep hygiene 
measures; and a combination of phototherapy and 
sleep hygiene measures. The study was approved by 
the Institutional Review Board and, even though it is 
a pilot study, was registered in the Brazilian Clinical 
Trials Registry – RBR-7jd2mm.
The individuals were randomized in blocks using 
the Research Randomizer software (http://www.
randomizer.org/form.htm) and each individual’s 
placement was put in opaque, sealed envelopes 
that were sequentially numbered. Immediately after 
randomization, demographic data and initial measures 
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were collected from the participants, followed by the 
implementation of the intervention to which each 
participant was assigned. Initial orientation was 
provided by the researcher to all the participants 
individually in a private room and lasted 20 minutes. 
This orientation consisted of an oral presentation and 
a dialogue concerning the intervention and a leaflet 
containing the same information provided verbally was 
handed to the participants.  All groups were followed-
up via telephone with weekly calls during 12 weeks to 
reinforce the respective interventions and collect any 
information concerning potential intercurrences since 
the last contact.
The participants in the control group (C) received 
general guidance regarding their heart disease and 
the use of medications prescribed by their physicians, 
without specifically mentioning sleep problems.
The participants in the phototherapy group (PT) 
were instructed to have 40 minutes of sun exposure 
daily in the first half of the morning. The morning 
period was chosen to protect the patients against 
potential harm caused on the individuals’ skins by sun 
exposure.
The participants in the group addressing sleep 
hygiene measures (SHM) received instructions 
regarding habits that improve sleep, such as: not 
going to bed unless already sleepy; getting out of 
the bed if not asleep within 20 minutes; including 
relaxation activities in their daily routines before going 
to bed; keeping regular bedtime hours; not reading, 
writing, eating, watching TV, speaking on the phone, or 
playing cards in bed; not eating heavy meals (difficult 
to digest) close to bedtime; not exercising intensively 
within six hours before bedtime; not drinking coffee, 
black or mate tea, soft drinks, hot cocoa or alcohol 
from 4 to 6 hours before bedtime, and not smoking at 
least 4 to 6 hours before bedtime.
The participants in the group that received a 
combination of phototherapy and sleep hygiene 
measures (PT+SHM) received the instructions 
previously mentioned regarding both interventions. 
The participants in this group and those in the 
phototherapy group were instructed to apply sun 
protection before sun exposure. 
Neither the interventionist nor the participants 
were blind to the assigned group. To avoid biases 
in the assessment and interpretation of results, an 
evaluator who did not take part in the interventions 
collected data at the baseline and during follow-ups 
without knowing to which group the participants 
were assigned. The participants were instructed not 
to reveal the group to which they had been assigned 
during data collection. 
In weeks 4, 8 and 12, the participants were 
assessed in face-to-face visits. There was no contact 
with the participants between the 12th and 24th weeks, 
when they were assessed via telephone contact.
The initial assessment included demographic data 
(age, sex, marital status, occupation, and education) 
and clinical data (functional class measured by criteria 
of the New York Heart Association – NYHA(33), type 
of medical follow-up, and the presence of dyspnea). 
Another four instruments were applied in the initial 
assessment to screen for symptoms. The Dutch Fatigue 
Scale (DUFS)(36), adapted for Brazil(37), measures the 
fatigue of individuals on a daily basis and its total score 
ranges from 8 to 40 points (the higher the score, the 
more intense the fatigue). The Dutch Exertion Fatigue 
Scale (DEFS)(36), also adapted for Brazil, measures 
exertion fatigue and its total score ranges from 9 to 
45 points (higher scores indicate more intense fatigue 
associated with physical effort). The Baecke Habitual 
Physical Activity Questionnaire, adapted for Brazil(38), 
was used to measure the participants’ habitual 
physical activities for the last 12 months regarding 
three components: occupational activities, exercise, 
and leisure. The instrument is composed of 16 items 
assessing an individual’s pattern of physical activities 
over a long period of time in different contexts(38-40). 
Depression symptoms were assessed using the Center 
for Epidemiological Studies – Depression (CES-D), 
adapted for Brazil(41), with scores ranging from 0 to 
60, (scores >15 indicate the presence of depressive 
symptoms).
The participants were assessed for primary and 
secondary outcomes at the baseline and after 4, 8, 12 
and 24 weeks. The primary outcomes were quality of 
sleep and health-related quality of life. Adherence to 
the intervention was a secondary outcome. 
The Pittsburgh Sleep Quality Index (PSQI)(42), 
adapted for Brazil(43), was used to assess the subjective 
quality of sleep through seven sleep-related 
components. The sum of the scores obtained for each 
of the components results in a global score that ranges 
from 0 to 21 points (the higher the score, the worse 
one’s quality of sleep). The PSQI classifies individuals 
into good (≤5) and bad sleepers (>5)(43).
The Minnesota Living with Heart Failure 
Questionnaire (MLHFQ)(44) was adapted for Brazil and 
contains 21 items addressing the perception of patients 
regarding physical, socioeconomic and emotional 
aspects of HF. The MLHFQ measures health-related 
quality of life (HRQoL) and its total score ranges from 
0 to 105 (scores <24 indicate good HRQoL, scores 
from 24 to 45 indicated moderate HRQoL, and scores 
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>45 indicate poor HRQoL(45). Change of 5 points are 
considered clinically significant(46).
An Adherence to Intervention Index was 
developed by the authors to assess adherence to 
the intervention and was defined as the proportion 
of self-reported total number of days in which the 
intervention was actually implemented in relation 
to the total number of days in which the participant 
remained in the study.
The participants’ data were analyzed according 
to the groups in which they were assigned even 
when interventions were not followed as prescribed. 
Sociodemographic and clinical characteristics obtained 
at the baseline were compared between groups using 
Fisher’s exact text for categorical variables and the 
Kruskal-Wallis non-parametric test for the numerical 
variables. 
The means concerning the primary outcomes 
obtained in the 12th and 24th weeks were compared 
between the four groups through analysis of 
covariance, using the outcome’s initial value as the 
covariate(47). The effect of each intervention (in the 
12th and 24th weeks) was estimated as the difference 
between outcome values (final minus initial), divided 
by the initial outcome’s standard deviation(48). The 
level of significance for all the tests was established 
at 0.05, without adjustment for multiple comparisons. 
These results should be interpreted with caution 
since this is a pilot study and the results will serve 
to support the design of future studies rather than be 
used as definitive confirmatory results.
The Kruskal-Wallis non-parametric test was used 
to compare the medians of percentage of adherence 
between groups and was chosen because it does not 
assume a specific distribution of the data. When the 
global test is statistically significant, post hoc pairwise 
comparison of the medians are performed using 
Dunn’s test (49).
To explore the trajectory of the outcomes over the 
course of the follow-up weeks, a graph was created for 
each individual and group. Analyses were performed 
using the Statistical Package for the Social Sciences 
(SPSS) version 24 and R-Studio version 0.98.1074.
Results
Of the 159 eligible patients, 62 were excluded due 
to cognitive impairment and 65 refused to participate 
(unavailable to attend follow-up visits, lived in another 
city, reported dermatological problems, or reported 
good quality of sleep, despite the assessment’s 
results showing they had poor quality of sleep). One 
participant assigned to the PT+SHM died between the 
12th and 24th weeks.  Figure 1 shows the follow-up 
flowchart.
Table 1 shows a summary of the participants’ 
sociodemographic and clinical characteristics at the 
baseline according to assigned group, showing the 
groups were comparable.
Table 2 presents the means and standard 
deviations of the outcomes according to group and 
follow-up period. Even though the participants were 
randomly assigned to the groups, the PT+SHM group 
presented the lowest mean of initial PSQI (best quality 
of sleep) compared to other groups, a situation that 
may occur with very small samples. Over time, the 
means decreased in all the groups, and at the 12th-
week follow-up, the SHM presented the lowest 
mean, followed by the PT+SHM, control and PT. The 
covariance analysis shows that the initial scores were 
important for the score obtained at the end of 12 
weeks (p=0.02), but after adjustments, no difference 
was found between the groups (p=0.22). The lowest 
mean at the end of 24 weeks was obtained by the 
SHM, followed by the Control, PT+SHM and PT groups, 
with statistically significant initial scores (p=0.01) 
for the scores obtained at the 24th week, while the 
differences between the groups were not significant 
(p=0.29).
The means obtained by all the groups in the 
MLHFQ decreased (improved quality of life) over time. 
At the 12th week, the lowest mean was obtained by 
the Control group, followed by the PT+SHM, SHM and 
PT. At the 24th-week follow-up, the lowest mean was 
obtained by the Control group, followed by the SHM, 
PT+SHM and PT. Again, the initial score obtained on 
the MLHFQ was important to explaining the outcome 
at the 12th and 24th weeks (p=0.02 in both follow-ups) 
but no statistically significant difference was found 
between groups (p=0.40 and p=0.35 for the 12th and 
24th weeks).
Because this is a pilot study, the most important 
information refers to estimates of the effect of each 
type of intervention on the participants’ quality of 
sleep and health-related quality of life. Table 3 shows 
the estimates of the effects for the outcomes at the 
12th and 24th weeks. The highest effect for the PSQI 
was found in the SHM group, followed by the Control 
and PT groups, with the PT+SHM group showing the 
lowest effect. The highest effect for the MLHFQ was 
experienced by the Control group, followed by the SHM 
group, with lower effects experienced by the PT+SHM.
Figure 2 shows the trajectory of outcomes for 
each individual per group and follow-up including 
during the intervention. The trajectory of the groups’ 
medians is represented by black dots.
www.eerp.usp.br/rlae
5Santos MA, Conceição AP, Ferretti-Rebustini REL, Ciol MA, Heithkemper MM, Cruz DALM.
Figure 1- Follow-up flowchart. São Paulo, SP, Brazil, 2014
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Table 1 – Characteristics of the sample at the baseline according to the assigned group (N = 32). São Paulo, SP, 
Brazil, 2014
Characteristics Control (n=8) PT* (n=8) SHM† (n=8) PT*+SHM†(n=8) P-value‡
Males % (n) 50.0(4) 25.0 (2) 25.0 (2) 62.0 (5) 0.42
Age in years, Mean (SD§) 54.8 (6.9) 52.1 (11.8) 55.5 (12.4) 58.8 (11.0)
Median (Min, Max) 55.5 (41-63) 51.5 (34-70) 57.5 (28-71) 58.0 (42-76) 0.49
Married, % (n) yes 88.0 (7) 88.0 (7) 62.0 (5) 75.0 (6) 0.79
Employment, % (n)
Working (active) 12.0 (1) 25.0 (2) 12.0 (1) -
0.69
Unemployed 12.0 (1) 12.5 (1) 12.0 (1) 25.0 (2)
Retired 75.0 (6) 50.0 (4)) 38.0 (3) 50.0 (4)
On sick leave/ receiving financial support - 12.0 (1) 38.0 (5) 25.0 (2)
Schooling in years, Mean (SD§) 7.9 (6.1) 7.8 (3.0) 6.2 (3.4) 8.2 (5.9)
Median (Min, Max) 5.5 (1-20) 7.5 (4-11) 7.5 (0-11) 9.0 (0-17) 0.89
Functional class - NYHA║, % (n)
I - - 12.0 (1) 25.0 (2)
II 62.0 (5) 62.0 (5) 38.0 (3) 25.0 (2) 0.57
III 38.0 (3) 38.0 (3) 50.0 (4) 50.0 (4)
Follow-up, % (n)
Medical consultation 3.0 (37.5) 5.0 (62.5) 3.0 (37.5) 5.0 (62.5)
0.65
Medical and nursing consultation 5.0 (62.5) 3.0 (37.5) 5.0 (62.5) 3.0 (37.5)
Dyspnea % (n) 100 (8) 100 (8) 88.0 (7) 100 (8) 1
Cognitive state (MEEM¶), Mean (SD§) 28.0 (1.5) 27.5 (1.4) 26.8 (2.2) 26.4 (3.4)
Median (Min- Max) 28.0 (25 – 30) 28.0 (26 – 30) 27.5 (22 – 29) 27.5 (21 – 30) 0.63
Fatigue (DUFS**), Mean (SD§) 29.2 (6.6) 29.4 (9.1) 28.4 (7.5) 26.4 (8.8)
Median (Min - Max) 30.5 (17-37) 31.5 (15-39) 31.0 (13-36) 28.5 (12-36) 0.79
Exertion fatigue (DEFS††), Mean (SD§) 24.0 (8.8) 28.5 (14.0) 30.9 (14.1) 30.2 (14.7)
Median (Min - Max) 25.0 (13-38) 27.0 (10-45) 34.0 (9-44) 34.5 (9-45) 0.72
Exercise (BHPAQ‡‡), Mean (SD§) 7.59 (1.39) 6.88 (0.96) 6.73 (1.09) 6.73 (1.79)
Median (Min - Max) 7.56 (6.00-10.63) 6.81 (5.25-8.13) 6.56 (5.38-8.88) 6.62 (4.50-9.13) 0.50
Depressive Symptoms (CES-D§§), Mean (SD§) 22.4 (8.6) 19.3 (13.6) 28.2 (15.0) 18.1 (11.3)
Median (Min - Max) 19.5 (12-36) 18.0 (6-50) 28.0 (9-52) 14.0 (6-37) 0.40
*FT – Phototherapy; †SHM – Sleep Hygiene Measures; ‡Kruskal-Wallis test for numerical variables or Fisher’s exact test for categorical variables; §SD – 
Standard Deviation; ║NYHA - New York Heart Association; ¶MEEM – Mini-Mental State Exam (scores from 0 to 30 points; the higher the score, the better 
one’s cognitive state); **DUFS - Dutch Fatigue Scale (scores from 8 to 40 points; the higher the score, the more intense one’s symptoms); ††DEFS - Dutch 
Exertion Fatigue Scale (scores from 9 to 45 point; the higher the score, the more intense one’s symptoms); ‡‡BHPAQ – Baecke Habitual Physical Activity 
Questionnaire; §§CES-D - Center for Epidemiological Studies – Depression (scores from 0 to 60, scores >15 indicate the presence of depressive symptoms)
Table 2 – Means (standard deviation) of the primary and secondary outcomes according to follow-up and groups 
(N = 32). São Paulo, SP, Brazil, 2014
Outcomes Week Control PT* SHM† PT*+ SHM†
p-value
Baseline Group
Primary Outcomes
Quality of sleep: Pittsburgh 
Sleep Quality Inventory - PSQI 
0 12.4 (2.5) 12.4 (2.8) 12.0 (2.2) 10.5 (2.7)
4 5.8 (2.8) 8.9 (2.0) 5.8 (2.5) 6.0 (3.5)
8 4.2 (3.0) 7.4 (2.1) 4.5 (2.5) 6.1 (3.8)
12 5.6 (5.1) 7.4 (3.8) 3.6 (1.9) 4.4 (2.1) 0.02 0.22‡
24 3.8 (2.8) 4.2 (1.8) 2.9 (0.8) 3.8 (1.6) 0.01 0.29‡
Quality of life: Minnesota 
Living with Heart Failure 
Questionnaire - MLHFQ
0 51.0 (19.1) 55.9 (24.3) 55.2 (25.3) 49.1 (28.3)
4 30.2 (17.6) 37.9 (21.8) 37.2 (22.8) 35.0 (21.4)
8 18.2 (9.3) 38.3 (21.7) 33.2 (21.9) 32.0 (26.4)
12 17.8 (14.7) 37.0 (19.9) 27.6 (28.4) 22.3 (22.1) 0.02 0.40‡
24 14.9 (11.6) 30.6 (17.2) 20.2 (20.2) 21.8 (19.6) 0.02 0.35‡
Secondary Outcome
% Adherence to the intervention 12
Means (Standard Deviation) 94.2 (8.1) 74.0 (17.4) 90.9 (13.7) 78.0 (27.8)
Median  (Min.- Max.) 98.4 (78.0-100) 77.8 (41.0-95.0) 96.0 (60.0-100) 92.1 (30.0-98.0) 0.02§
*PT – Phototherapy; †SHM – Sleep Hygiene Measures; ‡Test of difference of means between groups using Covariance Analysis adjusted by initial values 
(week 0). §Kruskal-Wallis test for difference between groups of medians of intervention adherence. Missing data: one value was lost in the PT+SHM group 
at the 4th and 12th weeks and two were lost at the 24th week, one was lost in the PT group at the 8th week.
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Table 3 – Estimates of the effects of interventions according 
to group and follow-up. São Paulo, SP, Brazil, 2014
Outcome
Interventions 
Control PT* SHM† PT*+SHM†
PSQI‡
12 weeks -2.7 -2.6 -3.8 -2.1
24 weeks -3.4 -3.5 -4.2 -2.3
MLHFQ§
12 weeks -1.7 -0.8 -1.1 -0.9
24 weeks -1.9 -1.0 -1.4 -1.1
*PT – Phototherapy; †SHM – Sleep Hygiene Measures; ‡PSQI Quality of 
sleep – Pittsburgh Sleep Quality Index, §MLHFQ Quality of Life – Minnesota 
Living with Heart Failure Questionnaire
The medians obtained in both the PSQI and the 
MLHFQ show that sleep patterns improved rapidly 
(a strong decline in week 4, followed by smaller declines) 
in all the groups, except for the PT group; the improvement 
obtained with the PT intervention was slower and did not 
reach the result obtained by the other groups.
Adherence was measured according to the 
percentage of days in which individuals followed the 
instructions according to the intervention to which they 
were assigned, in relation to the number of days in which 
individuals remained in the study. The results based 
on self-reports provided via telephone are presented 
in Table 2. Greater variation in terms of adherence to 
intervention was found in the PT and PT+SHM groups. 
According to the Kruskal-Wallis test, the medians of the 
percentages of adherence per group (98.4% Control, 
96.0% SHM, 92.1% PT+SHM, and 77.8% PT) were 
statistically different (p = 0.02). Post hoc analysis 
showed that the PT group was statistically different from 
the Control group (p=0.04).
Control Phototherapy Sleep Hygiene Combined Therapy
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Figure 2 – Trajectories of the scores obtained from the Pittsburgh Sleep Quality Index (PSQI) and in the Minnesota 
Living with Heart Failure Questionnaire (MLHFQ) according to follow-up and assigned group. São Paulo, SP, Brazil, 2014
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Discussion
The four intervention groups presented improved 
quality of sleep and health-related quality of life at 
the end of the intervention period (12 weeks) and 
at the follow-up occurring in the 24th week, though 
the differences found between the groups were not 
statistically significant. The main objective of this study, 
however, was to support future studies in this field of 
research and, for this reason, the discussion focuses 
on potential changes and suggestions for the design of 
studies based on the experience of this study.
According to the literature, individuals who practice 
SHM or PT tend to have better quality of sleep than those 
who do not implement any of these therapies(13-14,23-27). 
Our conjecture was that a combination of SHM and PT 
would have a synergy and lead to improved results; 
however, this study did not obtain the expected results. 
The SHM group presented the best result, followed by 
the PT+SHM, PT and Control groups. The groups that 
included SHM may have obtained results in terms 
of quality of sleep because they have a well-defined 
component (instructions regarding sleep hygiene), which 
probably helped the individuals to adhere to the therapy. 
In this study, instructions concerning phototherapy 
included exposure to daily sunlight and a lack of effect 
may have been caused by poor adherence. Adherence 
may have depended on both the weather (having or not 
having sunlight) during the study’s period and on the 
individuals’ inability to expose themselves to available 
sunlight during the period necessary to obtain an effect. 
Initially, we expected that the Control group would 
not experience any improvement in sleep patterns. It 
is possible that the improvement experienced by the 
Control group is due to adherence to the self-care 
recommendations. Having knowledge of heart disease 
and correctly using medications may have an effect on 
an individual’s quality of sleep.
The same effects were observed for health-related 
quality of life among individuals with HF, with a decline 
of 33 points on the MLHFQ (5-point variations in the 
MLHFQ are considered clinically significant(46)). Among 
the four groups, the Control group obtained the best 
mean on the MLHFQ at the 12th and 24th weeks, showing 
that knowledge of the disease and encouragement to 
properly use prescribed medications may be a good 
intervention to improve patients’ quality of sleep and 
health-related quality of life. The Control group may 
not be considered a “pure” control because it was 
also contacted via telephone, a situation that does not 
normally occur in the care provided to these patients. 
The four groups received structured orientation and 
weekly telephone calls, intercalated by face-to-face 
visits; only the content of the orientation was different. 
The usual treatment provided in outpatient clinics does 
not include weekly telephone calls or reinforcement on 
how to manage symptoms, which can be considered 
a form of active intervention. If the purpose of future 
studies is to assess the effects of an intervention when 
compared to treatment that is usually provided, we 
suggest that the control group only receive treatment 
that is usually provided by outpatient clinics, without 
providing extra information or making extra contact. 
Otherwise, the effect experienced by the control group 
cannot be generalized to outpatients receiving the usual 
treatment. 
The use of control groups without treatment in 
clinical research is generally difficult to implement 
or is even unethical. The use of a control group 
receiving the usual treatment enables the assessment 
of an experimental intervention when compared 
to what patients usually receive over the course of 
their treatments, not affecting a study’s validity and 
utility(50-51). In order to advance in knowledge concerning 
sleep patterns of individuals with HF, it is important to 
compare a group receiving usual outpatient treatment 
with a group receiving instructions regarding the 
management of symptoms and groups receiving PH 
and SHM. The possibility of being assigned to a control 
group may be a problem in recruiting participants, who 
may refuse to participate in the study if assigned to a 
control group or if they independently seek or receive 
information regarding the interventions provided to the 
other experimental groups(50). One way to minimize the 
problem is to offer one of the experimental treatments 
to those originally assigned to a control group after the 
study is finished as a way to encourage participation.
Low cost, non-pharmacological therapies able to 
ease the management of the disease are desirable in 
any context of health. These therapies have the potential 
not only to improve quality of life, but also may lead 
to a decreased number of medical visits and unplanned 
hospitalizations. The interventions addressed in this 
study consisted of instructing individuals with HF at 
the beginning of the study and providing reinforcement 
and follow-up with patients via telephone calls. All 
the interventions were low cost, only involving the 
interventionist during face-to-face instructions and 
weekly telephone calls. 
All the interventions in this study improved the 
participants’ quality of sleep and health-related quality 
of life. Most individuals experienced improved sleep in 
the 4th week of therapy in all the groups. As the duration 
of the participants’ diseases was different, it is unlikely 
that the results were only due to the natural progress 
of the disease. A common factor to all the interventions 
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was the supply of self-care recommendations, focusing 
on the disease only (Control group) or on specific 
therapies to improve sleep, with reinforcement provided 
via telephone. Many studies have used telephone 
contact because it is a viable and low-cost alternative 
to implement interventions(52-56), and it is also a way 
to improve adherence to non-drug treatment(55). To 
continue this line of research, it would be important 
to compare these interventions with a pure control 
group (as mentioned before) and possibly to provide 
greater support that could promote self-care and sleep 
improvement within each therapy. It is very important 
to study the effects of these therapies on preventing 
intercurrences and unplanned medical visits and 
hospitalizations in long-term studies. 
In this study, self-reported adherence to therapy 
was quite high, though the phototherapy group 
reported a significantly lower adherence rate compared 
to the other groups. It is known that self-reported 
adherence tends to be overestimated compared to 
true adherence(57), often motivated by the participant’s 
desire to please the researcher or clinical professional, 
a phenomenon that is called “social desirability”(58).  It 
is possible that the high level of adherence found in this 
study was due to this phenomenon. The participants in 
the phototherapy group, however, reported adherence 
rates 20% below that reported by the other groups and 
perhaps this difference is related to the therapy itself, 
that is, the need to have exposure to sunlight daily. 
Future studies should adopt different forms to assess 
adherence and ask the reasons for no or low adherence 
to the protocol.
The study was planned to provide an inexpensive 
and simple form of phototherapy. It is possible that 
participants forgot or missed the in the morning when 
they needed to get sun exposure, or that there were 
rainy or overcast days, or even that the instructions 
may not have been sufficiently motivating to encourage 
the participants to adhere to the protocol. In the future, 
we suggest that instructions include a motivational 
component (e.g., explain that it is possible to get sun 
exposure even on an overcast day). A more expensive 
solution would be the inclusion of phototherapy light 
bulbs, to which individuals would be exposed for a 
certain period each the day.
The high level of control over this pilot study, such as 
selecting collaborating researchers, preparing the nurse 
who performed the interventions, and ensuring that the 
same interventionist would address all the groups, was 
intended to ensure reliability in the study’s results. This 
study was conducted in a specialized university hospital 
and, for this reason, the sample may not represent the 
Brazilian population of individuals receiving treatment 
for HF as a whole. It was not possible to measure the 
intensity of sunlight to which the phototherapy group 
and the group receiving the combined therapies were 
exposed, which does not allow us to quantify the exact 
intensity of these groups’ sun exposure.
Conclusion
This study showed the feasibility of the use of non-
pharmacological therapies to improve quality of sleep 
and health-related quality of life among individuals 
with HF. Phototherapy and sleep hygiene measures, by 
themselves or in combination with other therapies, as 
well as knowledge regarding how to handle symptoms 
are low-cost interventions, both for patients and the 
health system, with the potential to promote sleep 
improvement. The next logical step in this line of 
research is to compare these interventions with a pure 
control group based on the usual treatment provided in 
the public service. Estimates obtained in this study can 
support sample size and statistical power calculations 
necessary for a confirmatory study.
Simple and low-cost therapies have the potential 
to improve the quality of sleep and quality of life of 
patients with HF, potentially influencing their health and 
the use of health services. Thus, these therapies should 
be investigated and eventually used in clinical practice. 
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